Advertisement Intellection and Bruker sign collaboration agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Intellection and Bruker sign collaboration agreement

Bruker, a manufacturer of X-ray diffraction and X-ray spectrometry equipment, and Intellection have announced a new strategic collaboration agreement which builds on the existing original equipment manufacturer relationship between the companies.

Under this agreement, Intellection will expand its range of products and services, directly supplying XRF (X-ray fluorescence) and XRD (X-ray diffraction) systems from Bruker to its customers. This will reportedly allow both companies to develop highly competitive global sales strategies.

Calvin Treacy, Intellection’s CEO, said: “Intellection’s own technological credentials are impeccable, with our Qemscan solutions the international market leader across the resources sector. Bruker’s XRD and XRF technologies complement Qemscan analysis, making them an excellent business fit for us.”